News & Updates
Filter by Specialty:

T2D treatment goal shifts from glucose centricity to end-organ protection
28 May 2025
byKanas Chan
With the advent of disease-modifying agents such as tirzepatide, the current treatment goal for type 2 diabetes (T2D) extends beyond merely managing glycaemic levels to focusing on a broader approach that emphasizes end-organ protection.